TRIFECTA THERAPEUTICS LLC

Trifecta Therapeutics LLC specializes in skin surface device adhesives, specifically products like POPS. These are designed to securely attach medical devices or dressings to the skin for temporary use in clinical or homecare settings, helping to minimize the need for frequent repositioning.

Trifecta Therapeutics LLC is headquartered in the United States. As a manufacturer, it develops products in compliance with applicable U.S. regulatory standards, including those governing Class I medical devices.

Trifecta Therapeutics LLC’s products, such as POPS, fall under Class I medical device classification in the U.S. This classification applies to low-risk devices that pose minimal potential harm to patients, requiring less stringent regulatory oversight than higher-risk categories.

Yes, Trifecta Therapeutics LLC’s devices are included in the FDA’s Unique Device Identifier (UDI) database. This listing ensures traceability and transparency in the regulatory system, allowing for easier identification and tracking of the company’s products.